Technology M&A Advisory Healthcare Global

M&A Advisory

Lazard

Full Credential Description

Merck KGaA. Germany, United States. Announced Date 20/12/2018. Closed Date 28/12/2018. Deal value: $175m. Merck KGaA, Darmstadt, Germany, assigns Chimeric Antigen Receptor T-cell (CAR-T) rights to Intrexon. Industry: Merck KGaA is a global science and technology company specializing in healthcare, life science, and performance materials.

Back to Search Contact Business